CoapTech Competitors and Similar CompaniesClear all
CoapTech's competitors and similar companies include Alcresta and Eyenovia.
 Alcresta Alcresta develops enzyme-based nutritional products for infants and adults with acute and chronic diseases. |  Eyenovia Eyenovia is a late-stage biopharmaceutical company with three lead programs in glaucoma, mydriasis and dry eye with a transformative ophthalmic delivery platform. | ||
Founding Date | Founding Date 2016 | Founding Date 2011 | Founding Date 2014 |
Type | Type Private | Type Private | Type Public |
Tags | |||
Locations | Locations Baltimore, US HQ | Locations Newton, US HQ | Locations New York, US HQ |
Employees | Employees 2717% increase | Employees 82 | Employees 22100% increase |
Funding | |||
Latest funding round | Latest funding round $ 1.2m (over 6 years ago) | Latest funding round $ 60m (over 8 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 3.6m | Total funding raised $ 139.4m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Alcresta
HQ
Newton, US
Employees
82
Alcresta develops enzyme-based nutritional products for infants and adults with acute and chronic diseases.
View companyEyenovia
HQ
New York, US
Employees
22
Eyenovia is a late-stage biopharmaceutical company with three lead programs in glaucoma, mydriasis and dry eye with a transformative ophthalmic delivery platform.
View company